Association of Pro-inflammatory Dietary Intake and Non-Alcoholic Fatty Liver Disease: Findings from Iranian case-control study
Abstract
Abstract.Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is considered as a major health problem in the world. There is much evidence that diet and dietary factors play an important role in inflammation, and consequently pathogenesis of NAFLD. To investigate the role of diet in the development of inflammation, we can use the Dietary Inflammatory Index (DII), which has been shown to be predictive of levels of inflammatory markers. Methods: 295 incident cases were selected using the convenience-sampling procedure, and 704 controls randomly were selected from the same clinic and among the patients who had no hepatic steatosis and were frequency-matched on age (±5 years) and sex. The DII was computed based on dietary intake from 168-item FFQ. Logistic regression models were used to estimate multivariable ORs. Results: Subjects in tertile 3 had 1.57 (95% CI: 1.13–2.20), 1.78 (95% CI: 1.19–2.67), and 2.02 (95% CI: 1.32–3.09) times higher odds of developing NAFLD, compared to subjects in tertile 1 in models 1 (adjusted for age), 2 (model 1 + BMI, education, smoking, alcohol, diabetes, low density lipoprotein, triglycerides) and 3 (model 2 + aspartate transaminase/alanine transaminase), respectively. When used as a continuous variable, one unit increase in DII was associated with 1.16 (95% CI: 1.05, 1.29), 1.21 (95% CI: 1.107, 1.37) and 1.25 (95% CI: 1.10, 1.43) increase in odds of NAFLD in models one, 2 and 3 respectively. Conclusion: Subjects who consumed a more pro-inflammatory diet were at increased odds of NAFLD.
References
1 (2007) GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 25, 883–9.
2 (2014) Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran. Iran J Public Health. 43, 1275–1283.
3 (2014) Non alcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials. 9, 126–133.
4 (2004) Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol. 19, 854–858.
5 (2009) Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int. 29, 113–119.
6 (2010) Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 28, 155–61.
7 (2015) Non-alcohol fatty liver disease in Asia: Prevention and planning. World J Hepatol. 7, 1788–96.
8 (2016) Current management of non-alcoholic fatty liver disease. Rev Assoc Med Bras. 62, 872–878.
9 (2016) Pathophysiology of Non Alcoholic Fatty Liver Disease. Int J Mol Med Sci. 17, 12.
10 (2011) Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol Suppl. 106, 460–468.
11 (2016) Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus. J Clin Biochem Nutr. 59, 215–219.
12 (2016) Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children. Dig Dis Sci. 61, 1375–1386.
13 (2016) Nutritional therapy for nonalcoholic fatty liver disease. J Nutr Biochem. 29, 1–11.
14 (2010) Diet and inflammation. Nutr Clin Pract. 25, 634–640.
15 (2015) The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review. Gene. 562, 8–15.
16 (2016) Inflammation, mitochondrial metabolism and nutrition: the multi-faceted progression of non-alcoholic fatty liver disease to hepatocellular carcinoma. Hepatobiliary Surg Nutr. 5, 438–443.
17 (2009) Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study. BMC gastroenterology. 9, 16.
18 (2016) PARP1-mediated PPARalpha poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease. J Hepatol. 16, 30697–3.
19 (2006) A mediterranean diet is cost-effective in patients with previous myocardial infarction. J Nutr. 136, 1879–1885.
20 (2004) Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 292, 1440–1446.
21 (2005) A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr. 82, 1052–1058.
22 (2017) Association between maternal dietary inflammatory index (DII) and abortion in Iranian women and validation of DII with serum concentration of inflammatory factors: case-control study. Appl Physiol Nutr Metab. 42, 511–516.
23 (2006) Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab. 91, 439–446.
24 (2006) Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am J Clin Nutr. 84, 1062–1069.
25 (2000) Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care. 23, 733–738.
26 (2000) Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol. 152, 1065–1071.
27 (2009) A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr. 139, 2365–2372.
28 (2014) A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS). Public Health Nutr. 17, 1825–1833.
29 (2017) Association between Dietary Inflammatory Index (DII) and risk of prediabetes: a case-control study. Appl Physiol Nutr Metab. 42, 399–404.
30 (1999) Validity and reproducibility of a food frequency interview in a Multi-Cultural Epidemiology Study. Ann Epidemiol. 9, 314–324.
31 (2014) Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 17, 1689–96.
32 (2014) No significant independent relationships with cardiometabolic biomarkers were detected in the Observation of Cardiovascular Risk Factors in Luxembourg study population. Nutr Res. 34, 1058–1065.
33 (2015) Major dietary patterns in Iranian adolescents: Isfahan Healthy Heart Program, Iran. ARYA Atheroscler. 11, 61–68.
34 (2015) Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 9, 519–527.
35 (2015) Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study. Br J Nutr. 113, 665–671.
36 (2015) Construct validation of the dietary inflammatory index among postmenopausal women. Ann Intern Med. 25, 398–405.
37 (2018) The association between the Index of Nutritional Quality (INQ) and breast cancer and the evaluation of nutrient intake of breast cancer patients: A case-control study. Nutr. 45, 11–16.
38 (2017) The Association Between Index of Nutritional Quality (INQ) and Glioma and Evaluation of Nutrient Intakes of These Patients: A Case-Control Study. Nutr Cancer. 1–8.
39 (2018) The Association Between Index of Nutritional Quality (INQ) and Gastric Cancer and Evaluation of Nutrient Intakes of Gastric Cancer Patients: A Case-Control Study. Int J Cancer Manag. (in press) p. e9747.
40 (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 30, 1212–1218.
41 (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 50, 1844–1850.
42 (2002) NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 35, 373–379.
43 (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology. 35, 367–372.
44 (2005) Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 90, 1578–1582.
45 (2006) The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 91, 4753–4761.
46 (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 102, 42–47.
47 (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem. 279, 32345–32353.
48 (2008) Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab. 19, 371–379.
49 (2015) NAFLD: a multisystem disease. J Hepatol. 62, S47–64.
50 (2016) Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis. PLoS One. 11, e0149783.